As we observed that RBPMS was reduced at the RNA and protein levels in serous ovarian cancer patients when compared with normal ovaries, we investigated the RBPMS protein levels in cisplatin-sensitive serous ovarian cancer cells. The gene discussed is RBPMS; the disease is ovarian serous adenocarcinoma.